IWE

Azosemide

Created:	2022-04-14
Last modified:	2023-04-26

Find Related PDB Entry
2 entries where IWE is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	0
Bond Count	36
Aromatic Bond Count	16

2D diagram of IWE

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Azosemide
Synonyms	2-chloranyl-5-(1~{H}-1,2,3,4-tetrazol-5-yl)-4-(thiophen-2-ylmethylamino)benzenesulfonamide
Systematic Name (OpenEye OEToolkits)	2-chloranyl-5-(1~{H}-1,2,3,4-tetrazol-5-yl)-4-(thiophen-2-ylmethylamino)benzenesulfonamide
Formula	C₁₂ H₁₁ Cl N₆ O₂ S₂
Molecular Weight	370.838
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	N[S](=O)(=O)c1cc(c(NCc2sccc2)cc1Cl)c3[nH]nnn3
SMILES	OpenEye OEToolkits	2.0.7	c1cc(sc1)CNc2cc(c(cc2c3[nH]nnn3)S(=O)(=O)N)Cl
Canonical SMILES	CACTVS	3.385	N[S](=O)(=O)c1cc(c(NCc2sccc2)cc1Cl)c3[nH]nnn3
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(sc1)CNc2cc(c(cc2c3[nH]nnn3)S(=O)(=O)N)Cl
InChI	InChI	1.06	InChI=1S/C12H11ClN6O2S2/c13-9-5-10(15-6-7-2-1-3-22-7)8(12-16-18-19-17-12)4-11(9)23(14,20)21/h1-5,15H,6H2,(H2,14,20,21)(H,16,17,18,19)
InChIKey	InChI	1.06	HMEDEBAJARCKCT-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB08961
Name	Azosemide
Groups	investigational
Description	Azosemide is a loop diuretic used to treat hypertension, edema, and ascites.
Synonyms	azosemida 5-(4'-chloro-5'-sulfamoyl-2'-thenylaminophenyl)tetrazole 2-chloro-5-(1H-tetrazol-5-yl)-N4-2-thenylsulfanilamide Azosemide azosemidum azosémide
Categories	Amides Amines Aniline Compounds Benzene Derivatives Diuretics Natriuretic Agents Sodium Potassium Chloride Symporter Inhibitors Sulfonamides Sulfones Sulfur Compounds
CAS number	27589-33-9

Related Resource References

Resource Name	Reference
PubChem	2273
ChEMBL	CHEMBL1097235
ChEBI	CHEBI:31248

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.